Supression of telomerase activity in HL60 cells after treatment with differentiating agents - PubMed (original) (raw)
Affiliations
- PMID: 8709642
Supression of telomerase activity in HL60 cells after treatment with differentiating agents
D Xu et al. Leukemia. 1996 Aug.
Abstract
The human promyelocytic leukemic HL60 cells are immortal and as such express high levels of telomerase activity. All-trans retinoic acid (ATRA) and 1 alpha, 25 dihydroxyvitamin D3 (VD3) induce differentiation of HL60 cells into CD11b+ mature granulocytes and monocytes, respectively. We studied telomerase activity after differentiation of HL60 cells. A marked inhibition of the enzyme activity was observed in the differentiated CD11b+ cells after 72-120 h treatment with either differentiating agent. In contrast, the VD3-treated CD11b- HL60 cells, which failed to undergo differentiation and human erythroleukemic cell line K562, exposed to ATRA retained high levels of telomerase activity. This finding suggests, that telomerase activity is repressed as a differentiation-associated event in HL60 cells. Our results provide the first evidence that immortal leukemic cells, like normal human cells, have a telomerase repressing mechanism which can be activated by differentiation and thus lead to the suppression of telomerase activity. This in vitro model may be useful for studies of the mechanisms controlling telomerase activity and in the search for physiological telomerase modulators.
Similar articles
- Downregulation of telomerase activity in HL60 cells by differentiating agents is accompanied by increased expression of telomerase-associated protein.
Reichman TW, Albanell J, Wang X, Moore MA, Studzinski GP. Reichman TW, et al. J Cell Biochem. 1997 Oct 1;67(1):13-23. J Cell Biochem. 1997. PMID: 9328835 - Modulation of CD157 expression in multi-lineage myeloid differentiation of promyelocytic cell lines.
Hussain AM, Lee HC, Chang CF. Hussain AM, et al. Eur J Cell Biol. 2000 Oct;79(10):697-706. doi: 10.1078/0171-9335-00099. Eur J Cell Biol. 2000. PMID: 11089918 - Multistep regulation of telomerase during differentiation of HL60 cells.
Yamada O, Ozaki K, Nakatake M, Akiyama M, Kawauchi K, Matsuoka R. Yamada O, et al. J Leukoc Biol. 2008 May;83(5):1240-8. doi: 10.1189/jlb.1207848. Epub 2008 Feb 14. J Leukoc Biol. 2008. PMID: 18276798
Cited by
- Suppression of telomerase reverse transcriptase (hTERT) expression in differentiated HL-60 cells: regulatory mechanisms.
Xu D, Gruber A, Björkholm M, Peterson C, Pisa P. Xu D, et al. Br J Cancer. 1999 Jun;80(8):1156-61. doi: 10.1038/sj.bjc.6690480. Br J Cancer. 1999. PMID: 10376966 Free PMC article. - Telomerase activity in plasma cell dyscrasias.
Xu D, Zheng C, Bergenbrant S, Holm G, Björkholm M, Yi Q, Gruber A. Xu D, et al. Br J Cancer. 2001 Mar 2;84(5):621-5. doi: 10.1054/bjoc.2000.1655. Br J Cancer. 2001. PMID: 11237381 Free PMC article. - Natural and pharmacological regulation of telomerase.
Mergny JL, Riou JF, Mailliet P, Teulade-Fichou MP, Gilson E. Mergny JL, et al. Nucleic Acids Res. 2002 Feb 15;30(4):839-65. doi: 10.1093/nar/30.4.839. Nucleic Acids Res. 2002. PMID: 11842096 Free PMC article. Review. - Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation.
Pendino F, Flexor M, Delhommeau F, Buet D, Lanotte M, Segal-Bendirdjian E. Pendino F, et al. Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6662-7. doi: 10.1073/pnas.111464998. Epub 2001 May 22. Proc Natl Acad Sci U S A. 2001. PMID: 11371621 Free PMC article. - Genetic and epigenetic trends in telomere research: a novel way in immunoepigenetics.
Melicher D, Buzas EI, Falus A. Melicher D, et al. Cell Mol Life Sci. 2015 Nov;72(21):4095-109. doi: 10.1007/s00018-015-1991-2. Epub 2015 Jul 20. Cell Mol Life Sci. 2015. PMID: 26190020 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials